Building High-Performance Sponsor-CRO Partnerships Across the Clinical Trial Lifecycle

This case study describes the mitigation and mid-trial corrective efforts employed by Aixial Group when an imaging equipment failure and subsequent recall

This case study describes the mitigation and mid-trial corrective efforts employed by Aixial to ensure successful outcomes in neuro…

Learn how Aixial ensures patient safety and regulatory compliance in personalised lithium-based clinical trials for bipolar I disorder.

Ovarian cancer is one of the most lethal gynecologic malignancies worldwide, often diagnosed at an advanced stage due to subtle or non-specific symptoms.

Pancreatic cancer is the 12th most common cancer in the world and remains one of the deadliest, with a five-year survival rate of only 13%, despite recent progress.

Did you know that lung cancer is the most diagnosed cancer in the world? In 2022, it accounted for 12.4% of all new cancer cases and 18.7% of deaths.

Prostate cancer is on the increase globally, especially in men under the age of 50, and in 2022 there were 1.47 million new cases.

Radiopharmaceutical therapy utilizes radioactive atoms to target and precisely treat cancer cells.

Conducting a Phase I First-In-Human (FIH) trial for Wilson’s Disease presents unique challenges due to the rarity…